Table 1

Baseline demographic and clinical of children with presumptive TB at Simão Mendes hospital in Guinea-Bissau (July 2019 to April 2020)

Confirmed TB (n=27)Unconfirmed TB (n=62)TB total (n=89)Unlikely TB (n=50)Total*OR (95% CI)P value
Age group (years), n (%)
<10 (0)11 (17.7)11 (12.4)5 (10)16 (11.5)1.2 (0.4 to 3.7)0.80
1-<56 (22.2)17 (27.4)23 (25.8)16 (32)39 (28.1)0.8 (0.4 to 1.7)0.49
5–1521 (77.8)34 (54.8)55 (61.8)29 (58)84 (60.4)Ref
Median (IQR) age8 (5–12)6 (1–11)8 (2–12)6.5 (1–11)7 (1–11)
Gender, n (%)
Male9 (33.3)38 (61.3)47 (52.8)28 (56)75 (54)0.9 (0.5 to 1.9)0.82
Female18 (66.7)22 (35.5)40 (44.9)22 (44)62 (44.6)Ref
Missing0 (0)2 (3.2)2 (2.2)0 (0)2 (1.4)(0.1 to −1)0.54
Nutrition status, n (%)
SAM16 (59.3)42 (67.7)58 (65.2)25 (50)83 (59.7)2.2 (1 to 4.7)0.039
MAM3 (11.1)3 (4.8)6 (6.7)3 (6)9 (6.5)1.9 (0.4 to 13.2)0.48
No malnourished8 (29.6)14 (22.6)22 (24.7)21 (42)43 (30.9)Ref
Missing0 (0)3 (4.8)3 (3.4)1 (2)4 (2.9)2.9 (0.2 to 157.4)0.61
HIV status, n (%)
Positive9 (33.3)31 (50)40 (44.9)19 (38)59 (42.4)1.3 (0.7 to 2.7)0.43
Negative18 (66.7)31 (50)49 (55.1)31 (62)80 (57.6)Ref
CD4 count, n (%)
<2004 (14.8)13 (21.0)17 (19.1)7 (14)24 (17.3)1.2 (0.4 to 4.0)0.75
>2005 (18.5)17 (27.4)22 (24.7)11 (22)33 (23.7)Ref
HIV negative18 (66.7)32 (51.6)50 (56.2)32 (64)82 (59)0.8 (0.3 to 1.8)0.57
Median (IQR) CD4 count232 (54–473)342 (68–619)291 (68–572)328 (99–954)306 (71–647)
ART status, n (%)
ART naïve1 (3.7)8 (12.9)9 (10.1)1 (2)10 (7.2)5.8 (0.7 to 267.4)0.14
ART experienced7 (25.9)21 (33.9)28 (31.5)18 (36)46 (33.1)Ref
Missing data1 (3.7)2 (3.2)3 (3.4)03 (2.2)
TB contact, n (%)
Yes14 (51.9)31 (50)45 (50.6)18 (36)63 (45.3)1.8 (0.9 to 3.7)0.098
No13 (48.1)31 (50)44 (49.4)32 (64)76 (54.7)Ref
Past TB treatment, n (%)
Yes1 (3.7)6 (9.7)7 (7.9)3 (6)10 (7.2)1.3 (0.3 to 8.3)1.00
No26 (96.3)55 (88.7)81 (91)46 (92)127 (91.4)Ref
Unknown0 (0)1 (1.6)1 (1.1)1 (2)2 (1.4)0.6 (0.01 to 45.5)1.00
Clinical characteristicsRR (95% CI)P value
TB Type, n (%)
PTB11 (40.7)44 (71)55 (61.8)0 (0)55 (39.6)
EPTB8 (29.6)2 (3.2)10 (11.2)0 (0)10 (7.2)
PTB and EPTB8 (29.6)16 (25.8)24 (27)0 (0)24 (17.3)
Unlikely TB0 (0)0 (0)0 (0)50 (100)50 (36)
Signs and symptoms, n (%)
Cough18 (66.7)55 (88.7)73 (82)41 (82)114 (82)1 (0.7 to 1.4)0.584
Tachypnoea5 (18.5)5 (8.1)10 (11.2)2 (4)12 (8.6)1.3 (1 to 1.8)0.124
Hypoxaemia6 (22.2)34 (54.8)40 (44.9)9 (18)49 (35.3)1.5 (1.2 to 1.9)0.001
Fever18 (66.7)45 (72.6)63 (70.8)33 (66)96 (69.1)1.1 (0.8 to 1.4)0.345
Gibbous8 (29.6)5 (8.1)13 (14.6)4 (8)17 (12.2)1.2 (0.9 to 1.7)0.194
Lymph nodes7 (25.9)0 (0)7 (7.9)5 (10)12 (8.6)0.9 (0.6 to 1.5)0.444
Subacute meningitis0 (0)0 (0)0 (0)1 (2)1 (0.7)0.360
Distended abdomen1 (3.7)4 (6.5)5 (5.6)1 (2)6 (4.3)1.3 (0.9 to 1.9)0.296
Osteoarticular1 (3.7)4 (6.5)5 (5.6)0 (0)5 (3.6)1.6 (1.4 to 1.8)0.207
Pleural effusion7 (25.9)20 (32.3)27 (30.3)0 (0)27 (19.4)1.8 (1.5 to 2.1)<0.001
  • P-values shown in bold highlight statistical significance at p<0.05 level of significance.

  • *OR from bivariate analysis.

  • ART, antiretroviral therapy; EPTB, extra pulmonary TB; MAM, moderate acute malnutrition; PTB, pulmonary TB; SAM, severe acute malnutrition; TB, tuberculosis.